Sensorion announces positive results from a preclinical trial in the recovery of hearing after acoustic trauma 

Read

 Sensorion successfully completes the first part of clinical trial SENS-111

Read

Sensorion launches its IPO on Paris Alternext 

Read

Sensorion announces the registration of its document de base with the Autorité des Marchés Financiers (AMF) within the framework of its planned IPO on the Alternext Paris

Read

Sensorion completes a new funding round, for an amount of up to € 4 million, to begin the human clinical trial phase

Read

Next events